Tocopherols: Clinical Trials

38 trials of Tocopherols, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 11 unknown, 3 recruiting, 3 terminated. 10 Not applicable, 10 Phase 2, 7 Phase 3, 7 Phase 4, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 6, Unknown 4
Phase 210Completed 5, Recruiting 2, Unknown 2, Withdrawn 1
Phase 37Unknown 4, Active not recruiting 1, Recruiting 1, Terminated 1
Phase 47Completed 5, Terminated 1, Unknown 1
Phase 13Completed 3
Early Phase 11Completed 1

Follow Tocopherols: new trials by email Literature Review of Tocopherols trials Research Report on Tocopherols

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
Pravastatin (drug), Pentoxifylline, ketoprofen - Fibrosis Syndrome, Lymphedema
Phase 2RecruitingM.D. Anderson Cancer Center2502025-08-082026-07-24
Vitamin E Plus Mefenamic Acid Versus Mefenamic Acid Alone for Treating Primary Dysmenorrhea in Women
Mefenamic acid, Vitamin E capsule - Dysmenorrhea Primary, Vitamin E
Phase 4CompletedNishtar Medical University602025-07-152026-03-12
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
Pravastatin, Pentoxifylline, Tocopherol - Lymphedema, Fibrosis
Phase 2RecruitingM.D. Anderson Cancer Center2952025-02-132026-09-11
Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible
modified PENTOCLO (mPENTOCLO), sham mPENTOCLO - Osteoradionecrosis, Osteoradionecrosis of Jaw
Phase 3RecruitingSunnybrook Health Sciences Centre242025-01-162025-09-12
Comparison of Effectiveness of Obeticholic Acid With Vitamin E in Patients of Non-alcoholic Fatty Liver Disease
Obeticholic Acid 10 MG, Vitamin E 400mg - Non Alcoholic Fatty Liver Disease
Phase 2CompletedKing Edward Medical University902023-08-242025-08-05
The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis
Ascorbic acid, Tocopherol, Placebo capsule - Restless Legs Syndrome, End Stage Renal Disease
Phase 3UnknownKing Abdulaziz University1602022-11-012022-08-24
Antioxidants Vitamins and Muscle Damage
Dietary Supplement: Vitamin C and vitamin E, Placebo - Oxidative Stress
Not applicableCompletedUniversidad Europea de Madrid182022-02-102022-04-07
Clinical Efficacy Analysis of Resveratrol in the Treatment of Primary Ovarian Insufficiency
Resveratrol, Vitamin E - Primary Ovarian Insufficiency
Not applicableUnknownAffiliated Hospital of Nantong University1502022-02-012022-06-08
OMTrigger Inject- Treating Trigger Points: Comparing Muscle Energy Technique vs. Lidocaine Needling Technique
OMT - Myofascial Pain Syndrome
TerminatedAtlantiCare Regional Medical Center302022-01-122025-02-03
Role of Vitamin E in Reducing Dry Socket
Vitamin E application - Dry Socket
Phase 4CompletedAin Shams University402022-01-012023-08-09
The Effect of Vitamin D Supplementation on Dental Implant Osseointegration: A Randomized Controlled Trial
Vitamin D3, Vitamin E 400 - Osseointegration Failure of Dental Implant
Not applicableCompletedZiauddin University1002021-09-012024-02-23
Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.
All trans-retinoic acid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone - Breast Cancer Female
Phase 3UnknownMahmoud Ramadan mohamed Elkazzaz1602021-08-012021-08-23
Antioxidant Vitaminas and Hypertrophy Adaptations to Resistance Training
Vitamin C and vitamin E, Placebo - Hypertrophy
Not applicableCompletedUniversidad Europea de Madrid302021-02-012021-08-03
Omega-3 Fatty Acids Plus Vitamin E Cosupplementation Versus Vitamin E in Fibrocystic Breast Patient
Omega 3 fatty acid, VitaE - Mastalgia
Phase 4UnknownCairo University1202021-01-012021-01-05
Impact of Topical Pentoxifylline and Tocopherol in Treatment and Prevention of Medically-related Osteonecrosis of the Jaws
Tocopherol and pentoxifilline topical gel, Placebo - Medically Related Osteonecrosis of the Jaws
Not applicableCompletedUniversity of Catania482020-04-022024-05-10
Lipid Peroxidation and Options Antioxidant Therapy for Secondary Lymphedema of the Lower Extremities
Micronised purified flavonoid fraction (diosmin+flavonoids expressed as hesperidin), Tocopherol, Elastic compression - Lower Extremity Lymphedema
Phase 4CompletedRyazan State Medical University1202019-09-012022-08-04
Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome.
Q10 Ubiquinol, Vitamin E, Multi-Vitamin B complex - Autism Spectrum Disorder, Phelan-McDermid Syndrome
Not applicableUnknownAntonio Persico2002019-03-092020-03-18
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
Pentoxifylline, Placebo, Tocopherol - Medication-related Osteonecrosis of the Jaw, Bisphosphonate-related Osteonecrosis of the Jaw
Phase 3Active not recruitingUniversity of Washington1002018-04-012026-04-29
Management of Mandibular ORN: PENTO as Medical Treatment
Pentoxifylline and Tocopherol - Osteoradionecrosis
Phase 4CompletedHospital Vall d'Hebron242016-02-012018-03-22
ANti-Oxidant in Variant Angina (ANOVA) Trial
Vitamin C and Vitamin E, Statin, Standard medication for variant angina - Variant Angina
Phase 4TerminatedSeoul National University Hospital3202014-09-012026-04-27

Showing 20 of 38. Sign in to see all of them.

Conditions studied

Fibrosis (3)  ·  Head and Neck Neoplasms (2)  ·  Kidney Failure, Chronic (2)  ·  Low Back Pain (2)  ·  Lymphedema (2)  ·  Osteonecrosis (2)  ·  Osteoradionecrosis (2)  ·  Renal Insufficiency, Chronic (2)  ·  Alzheimer Disease (1)  ·  Anemia (1)  ·  Angina Pectoris, Variant (1)  ·  Autism Spectrum Disorder (1)  ·  Autistic Disorder (1)  ·  Avitaminosis (1)  ·  Bisphosphonate-Associated Osteonecrosis of the Jaw (1)

Sponsors

M.D. Anderson Cancer Center (2)  ·  Universidad Europea de Madrid (2)  ·  Vanderbilt University (2)  ·  Affiliated Hospital of Nantong University (1)  ·  Aga Khan University (1)  ·  Ain Shams University (1)  ·  Antonio Persico (1)  ·  AtlantiCare Regional Medical Center (1)  ·  Cairo University (1)  ·  Chandan K Sen (1)  ·  Federal University of Health Science of Porto Alegre (1)  ·  French National Agency for Research on AIDS and Viral Hepatitis (1)  ·  Hadassah Medical Organization (1)  ·  Hospital Universitario de Canarias (1)  ·  Hospital Vall d'Hebron (1)

Countries

United States (14)  ·  Pakistan (4)  ·  Spain (4)  ·  Canada (2)  ·  Egypt (2)  ·  France (2)  ·  Italy (2)  ·  Australia (1)  ·  Brazil (1)  ·  China (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Russia (1)  ·  South Korea (1)  ·  Thailand (1)

Top investigators

Alp Ikizler, MD (2)  ·  Jonathan Himmelfarb, MD (2)  ·  Abbot R. Laptook, MD (1)  ·  Abhik Das, PhD (1)  ·  Adis Tasanarong, MD (1)  ·  Amr Ahmed (1)  ·  Antonio M. Persico, MD (1)  ·  Arthur J Dalton, PhD (1)  ·  Barbara J. Stoll, MD (1)  ·  Ben Safa, MD (1)  ·  Brenda B. Poindexter, MD MS (1)  ·  Brendan S Kelly, DO (1)  ·  Chandan Sen, PhD (1)  ·  Clifton Fuller, MD (1)

Results publications

PMID 12190139, PMID 19401528, PMID 19845233, PMID 22298568, PMID 24218460, PMID 26780276, PMID 29939770, PMID 31461186, PMID 31776782, PMID 32663271, PMID 34872836, PMID 35178319, PMID 35403929, PMID 35866376, PMID 37702300, PMID 8931529

NIH funding

R01AG016381 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD027851 (1), U10HD027856 (1), U10HD027871 (1), U10HD027880 (1), U10HD027904 (1), U10HD034216 (1), U10HD036790 (1), U10HD040492 (1), U10HD040689 (1), U10HD053089 (1), U10HD053109 (1)